【总结】开发变革性的肿瘤免疫治疗药物，造福全世界的癌症患者
科望医药是一家处于临床阶段的生物医药公司，致力于开发变革性的肿瘤免疫治疗药物，旨在造福全世界的癌症患者。公司的创新聚焦在肿瘤微环境的研究，探索和验证更有效的杀伤肿瘤的机制。基于自主开发的专利平台，科望医药已建立起全球创新的肿瘤免疫治疗产品管线，凭借自身卓越的研发能力和与国际生物医药企业的创新合作，科望医药持续努力将具有突破性价值的创新候选药物推进到临床。
Elpiscience is a clinical-stage biopharmaceutical company dedicated to developing life-changing immuno-oncology therapies fcancer patients worldwide. The company’s innovative approach is focused on targeting tummicroenvironment to identify effective mechanisms to kill cancer. A pipeline of novel molecules has been developed using its proprietary platforms. Through internal R&D expertise partnerships with global biopharmaceutical companies, Elpiscience endeavors to advance the programs with breakthrough value clinic use.
内容由
提供
恭喜您，提交成功！
您的编辑正在审核中，1个工作日内，会以邮件通知您结果
提交失败。
